In breast cancer, mammalian hepatitis B X-interacting protein (HBXIP) enhances the expression of METTL3 by suppressing the tumor suppressor, let-7 g, and forms a positive feedback loop to enhance the level of HBXIP by facilitating m6A modification of mRNA, which promotes cell proliferation [13]. The gene discussed is LAMTOR5; the disease is neoplasm.